Proposed NIH funding cuts are a pressing concern when one considers the broader impacts of reduced research funding.
The Artificial Intelligence in Pharmaceutical Market is forecasted to skyrocket from USD 3.24 billion in 2024 to $65.83 ...
Artificial intelligence is poised to dramatically reshape the process of developing and approving new medicines, according to ...
Vancouver company uses generative AI to identify potential molecules, saving millions of dollars and months compared to other ...
Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric, small-molecule ...
Viva Biotech is acknowledged for its pioneering AI-driven drug discovery platforms that accelerate timelines, reduce costs, and expand therapeutic innovation in the global pharmaceutical R&D ecosystem ...
Drug development and production rely on stringent quality controls, reproducibility, and verification. Biopharmaceuticals, including protein-based therapies, require extensive characterization, ...
Global CRDMO platform integrating discovery, development, and manufacturing, with a diversified footprint across Asia, Europe ...
Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...
C4X Discovery Holdings PLC. C4X Discovery Holdings Ltd. C4X Discovery announces selection of a once-daily development ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback